Comparison of the clinical outcomes of non-invasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome

The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expirato...

Full description

Saved in:
Bibliographic Details
Published inMedicine (Baltimore) Vol. 100; no. 4; p. e24443
Main Authors Khatib, Mohamad Y., Peediyakkal, Mohamed Z., Elshafei, Moustafa S., Elzeer, Hani S., Ananthegowda, Dore C., Shahen, Muhsen A., Abdaljawad, Wael I., Shaik, Karimulla S., Kannappilly, Nevin, Mohamed, Ahmed S., Soliman, Ahmed A., Nashwan, Abdulqadir J.
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 29.01.2021
Subjects
Online AccessGet full text
ISSN0025-7974
1536-5964
1536-5964
DOI10.1097/MD.0000000000024443

Cover

Abstract The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expiratory pressure, which could be resolved with the use of the helmet NIV. NIV facemask will be applied as per the facial contour of the patient. NIV helmet is a transparent hood and size will be measured as per the head size. Both groups will have a standard protocol for titration of NIV.Patients aged more than 18 years old and diagnosed with acute respiratory distress syndrome as per Berlin definition will be enrolled in the study after signing the informed consent. Subjects who met the inclusion criteria will receive 1 of the 2 interventions; blood gases, oxygenation status [Po2/Fio2] will be monitored in both groups. The time of intubation will be the main comparison factor among the 2 groups. The primary and secondary outcomes will be measured by the number of patients requiring endotracheal intubation after application of helmet device, Improvement of oxygenation defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100, duration of mechanical ventilation via an endotracheal tube, intensive care unit length of stay, death from any cause during hospitalization at the time of enrolment, need for proning during the hospital stay, intensive care unit mortality, and the degree to which overt adverse effects of a drug can be tolerated by a patient including feeding tolerance. NCT04507802. May 2020.
AbstractList The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expiratory pressure, which could be resolved with the use of the helmet NIV. NIV facemask will be applied as per the facial contour of the patient. NIV helmet is a transparent hood and size will be measured as per the head size. Both groups will have a standard protocol for titration of NIV.Patients aged more than 18 years old and diagnosed with acute respiratory distress syndrome as per Berlin definition will be enrolled in the study after signing the informed consent. Subjects who met the inclusion criteria will receive 1 of the 2 interventions; blood gases, oxygenation status [Po2/Fio2] will be monitored in both groups. The time of intubation will be the main comparison factor among the 2 groups. The primary and secondary outcomes will be measured by the number of patients requiring endotracheal intubation after application of helmet device, Improvement of oxygenation defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100, duration of mechanical ventilation via an endotracheal tube, intensive care unit length of stay, death from any cause during hospitalization at the time of enrolment, need for proning during the hospital stay, intensive care unit mortality, and the degree to which overt adverse effects of a drug can be tolerated by a patient including feeding tolerance.ABSTRACTThe main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expiratory pressure, which could be resolved with the use of the helmet NIV. NIV facemask will be applied as per the facial contour of the patient. NIV helmet is a transparent hood and size will be measured as per the head size. Both groups will have a standard protocol for titration of NIV.Patients aged more than 18 years old and diagnosed with acute respiratory distress syndrome as per Berlin definition will be enrolled in the study after signing the informed consent. Subjects who met the inclusion criteria will receive 1 of the 2 interventions; blood gases, oxygenation status [Po2/Fio2] will be monitored in both groups. The time of intubation will be the main comparison factor among the 2 groups. The primary and secondary outcomes will be measured by the number of patients requiring endotracheal intubation after application of helmet device, Improvement of oxygenation defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100, duration of mechanical ventilation via an endotracheal tube, intensive care unit length of stay, death from any cause during hospitalization at the time of enrolment, need for proning during the hospital stay, intensive care unit mortality, and the degree to which overt adverse effects of a drug can be tolerated by a patient including feeding tolerance.NCT04507802.TRIAL REGISTRATION NUMBERNCT04507802.May 2020.PROTOCOL VERSIONMay 2020.
The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expiratory pressure, which could be resolved with the use of the helmet NIV. NIV facemask will be applied as per the facial contour of the patient. NIV helmet is a transparent hood and size will be measured as per the head size. Both groups will have a standard protocol for titration of NIV.Patients aged more than 18 years old and diagnosed with acute respiratory distress syndrome as per Berlin definition will be enrolled in the study after signing the informed consent. Subjects who met the inclusion criteria will receive 1 of the 2 interventions; blood gases, oxygenation status [Po2/Fio2] will be monitored in both groups. The time of intubation will be the main comparison factor among the 2 groups. The primary and secondary outcomes will be measured by the number of patients requiring endotracheal intubation after application of helmet device, Improvement of oxygenation defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100, duration of mechanical ventilation via an endotracheal tube, intensive care unit length of stay, death from any cause during hospitalization at the time of enrolment, need for proning during the hospital stay, intensive care unit mortality, and the degree to which overt adverse effects of a drug can be tolerated by a patient including feeding tolerance. NCT04507802. May 2020.
The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply NIV. However, some of the limitations of the NIV face mask were air leak, face mask intolerance, and requirement of high positive end expiratory pressure, which could be resolved with the use of the helmet NIV. NIV facemask will be applied as per the facial contour of the patient. NIV helmet is a transparent hood and size will be measured as per the head size. Both groups will have a standard protocol for titration of NIV. Patients aged more than 18 years old and diagnosed with acute respiratory distress syndrome as per Berlin definition will be enrolled in the study after signing the informed consent. Subjects who met the inclusion criteria will receive 1 of the 2 interventions; blood gases, oxygenation status [Po2/Fio2] will be monitored in both groups. The time of intubation will be the main comparison factor among the 2 groups. The primary and secondary outcomes will be measured by the number of patients requiring endotracheal intubation after application of helmet device, Improvement of oxygenation defined as PaO2/FiO2 ≥ 200 or increase from baseline by 100, duration of mechanical ventilation via an endotracheal tube, intensive care unit length of stay, death from any cause during hospitalization at the time of enrolment, need for proning during the hospital stay, intensive care unit mortality, and the degree to which overt adverse effects of a drug can be tolerated by a patient including feeding tolerance.
Author Shaik, Karimulla S.
Khatib, Mohamad Y.
Shahen, Muhsen A.
Mohamed, Ahmed S.
Elshafei, Moustafa S.
Soliman, Ahmed A.
Peediyakkal, Mohamed Z.
Ananthegowda, Dore C.
Kannappilly, Nevin
Nashwan, Abdulqadir J.
Abdaljawad, Wael I.
Elzeer, Hani S.
AuthorAffiliation Critical Care Medicine Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar
AuthorAffiliation_xml – name: Critical Care Medicine Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar
Author_xml – sequence: 1
  givenname: Mohamad Y.
  surname: Khatib
  fullname: Khatib, Mohamad Y.
  organization: Critical Care Medicine Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha, Qatar
– sequence: 2
  givenname: Mohamed Z.
  surname: Peediyakkal
  fullname: Peediyakkal, Mohamed Z.
– sequence: 3
  givenname: Moustafa S.
  surname: Elshafei
  fullname: Elshafei, Moustafa S.
– sequence: 4
  givenname: Hani S.
  surname: Elzeer
  fullname: Elzeer, Hani S.
– sequence: 5
  givenname: Dore C.
  surname: Ananthegowda
  fullname: Ananthegowda, Dore C.
– sequence: 6
  givenname: Muhsen A.
  surname: Shahen
  fullname: Shahen, Muhsen A.
– sequence: 7
  givenname: Wael I.
  surname: Abdaljawad
  fullname: Abdaljawad, Wael I.
– sequence: 8
  givenname: Karimulla S.
  surname: Shaik
  fullname: Shaik, Karimulla S.
– sequence: 9
  givenname: Nevin
  surname: Kannappilly
  fullname: Kannappilly, Nevin
– sequence: 10
  givenname: Ahmed S.
  surname: Mohamed
  fullname: Mohamed, Ahmed S.
– sequence: 11
  givenname: Ahmed A.
  surname: Soliman
  fullname: Soliman, Ahmed A.
– sequence: 12
  givenname: Abdulqadir J.
  surname: Nashwan
  fullname: Nashwan, Abdulqadir J.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33530249$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu1DAUtVARnRa-AAl5ySbFzyTeIKFpeUit2MDauuM4xNSJB9vJaH6Br8bTaXl0gTeW73ld-ZyhkylMFqGXlFxQopo3N5cX5M9hQgj-BK2o5HUlVS1O0KpMZdWoRpyis5S-E0J5w8QzdMq55EWhVujnOoxbiC6FCYce58Fi493kDHgc5mzCaNMBKNmVmxZIbrF4sVN2HrIros0eD9aPNuMl4R6MHSHdYjfhbcELL-GdywMGM2eLo01bFyGHuMedS7m8E077qYsl5zl62oNP9sX9fY6-vr_6sv5YXX_-8Gn97royvCWqYn3dQg8EzKZphJKSMOigFUIx0pPOgKSMSdoRoA0o20vVdQJ62tebVpqW83P09ui7nTej7UxZMoLX2-hGiHsdwOl_kckN-ltYdNNKUqu6GLy-N4jhx2xT1qNLxnoPkw1z0ky0NZVMsUPWq7-zfoc8FFAI6kgwMaQUba-Ny3c_W6Kd15ToQ9n65lI_Lrto-SPtg_3_VeKo2gWfbUy3ft7ZqAcLPg93dNkoVjHCKKFMkapMlOK_AOeJv6g
CitedBy_id crossref_primary_10_1002_hsr2_525
crossref_primary_10_1002_ccr3_4513
crossref_primary_10_1016_j_bja_2023_12_022
crossref_primary_10_5339_qmj_2023_29
crossref_primary_10_1002_hsr2_339
crossref_primary_10_1186_s13054_021_03746_8
crossref_primary_10_1097_MD_0000000000028637
crossref_primary_10_3389_fmed_2022_874250
Cites_doi 10.1186/cc13103
10.1007/s11739-012-0856-z
10.1001/jama.2016.0291
10.1007/s00134-012-2475-6
10.1097/01.CCM.0000251821.44259.F3
10.1007/s00134-012-2682-1
10.1001/jama.2016.6338
10.2214/ajr.148.3.501
10.4187/respcare.02319
10.1136/bmjopen-2020-040428
10.1097/00003246-200211000-00008
10.1097/00075198-200402000-00001
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
– notice: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1097/MD.0000000000024443
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1536-5964
EndPage e24443
ExternalDocumentID PMC7850696
33530249
10_1097_MD_0000000000024443
00005792-202101290-00099
Genre Clinical Trial Protocol
Journal Article
GrantInformation_xml – fundername: Hamad Medical Corporation
  grantid: MRC-01-20-616
GroupedDBID ---
.-D
.XZ
.Z2
01R
0R~
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AAWTL
AAXQO
AAYEP
ABASU
ABBUW
ABCQX
ABDIG
ABFRF
ABOCM
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
ADNKB
ADPDF
AE6
AEFWE
AENEX
AFBFQ
AFDTB
AGOPY
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
CS3
DIWNM
DU5
E.X
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FD6
FIJ
FL-
GNXGY
GQDEL
GROUPED_DOAJ
H0~
HLJTE
HYE
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
N9A
N~7
N~B
O9-
OAG
OAH
OB2
OHH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OUVQU
OVD
OVDNE
OVEED
OVIDH
OVLEI
OWV
OWW
OWZ
OXXIT
P2P
RIG
RLZ
RPM
RXW
S4R
S4S
TAF
TEORI
TSPGW
UNMZH
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
YOC
ZFV
ZY1
AAYXX
ADKSD
ADSXY
CITATION
8L-
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
ODA
7X8
5PM
ID FETCH-LOGICAL-c3809-2f68afa0acb77495502ada844920f0dca512251d0a17a9ef59dd4af1f6b85c833
ISSN 0025-7974
1536-5964
IngestDate Tue Sep 30 15:59:27 EDT 2025
Sun Sep 28 08:08:29 EDT 2025
Wed Feb 19 02:24:43 EST 2025
Wed Oct 01 06:32:01 EDT 2025
Thu Apr 24 23:05:25 EDT 2025
Fri May 16 03:48:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3809-2f68afa0acb77495502ada844920f0dca512251d0a17a9ef59dd4af1f6b85c833
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0003-4845-4119
OpenAccessLink http://dx.doi.org/10.1097/MD.0000000000024443
PMID 33530249
PQID 2486152923
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7850696
proquest_miscellaneous_2486152923
pubmed_primary_33530249
crossref_citationtrail_10_1097_MD_0000000000024443
crossref_primary_10_1097_MD_0000000000024443
wolterskluwer_health_00005792-202101290-00099
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210129
2021-01-29
2021-Jan-29
PublicationDateYYYYMMDD 2021-01-29
PublicationDate_xml – month: 01
  year: 2021
  text: 20210129
  day: 29
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hagerstown, MD
PublicationTitle Medicine (Baltimore)
PublicationTitleAlternate Medicine (Baltimore)
PublicationYear 2021
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Ferguson (R8-20250504) 2012; 38
Patel (R18-20250504) 2016; 315
Soliman (R5-20250504) 2020; 91
Force (R9-20250504) 2012; 307
Hess (R11-20250504) 2013; 58
Carrillo (R14-20250504) 2012; 38
Iqbal (R6-20250504) 2020; 91
Antonelli (R16-20250504) 2007; 35
Al Kuwari (R4-20250504) 2020; 10
Estenssoro (R2-20250504) 2002; 30
Greene (R10-20250504) 1987; 148
Bellani (R1-20250504) 2016; 315
Hess (R12-20250504) 2007; 52
Schwartz (R17-20250504) 2004; 49
Frutos-Vivar (R3-20250504) 2004; 10
Berg (R13-20250504) 2012; 7
Thille (R15-20250504) 2013; 17
Nair (R7-20250504) 2020; 91
References_xml – volume: 91
  start-page: 1
  year: 2020
  ident: R7-20250504
  article-title: Clinical outcome of eosinophilia in patients with COVID-19: a controlled study
  publication-title: Acta Bio Medica Atenei Parmensis
– volume: 17
  start-page: 1
  year: 2013
  ident: R15-20250504
  article-title: Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors
  publication-title: Critical Care
  doi: 10.1186/cc13103
– volume: 91
  start-page: 1
  year: 2020
  ident: R5-20250504
  article-title: Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study
  publication-title: Acta Bio Medica Atenei Parmensis
– volume: 7
  start-page: 539
  year: 2012
  ident: R13-20250504
  article-title: Noninvasive ventilation for acute respiratory failure: a review of the literature and current guidelines
  publication-title: Intern Emerg Med
  doi: 10.1007/s11739-012-0856-z
– volume: 315
  start-page: 788
  year: 2016
  ident: R1-20250504
  article-title: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries
  publication-title: JAMA
  doi: 10.1001/jama.2016.0291
– volume: 38
  start-page: 458
  year: 2012
  ident: R14-20250504
  article-title: Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-012-2475-6
– volume: 35
  start-page: 18
  year: 2007
  ident: R16-20250504
  article-title: A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome
  publication-title: Crit Care Med
  doi: 10.1097/01.CCM.0000251821.44259.F3
– volume: 52
  start-page: 568
  year: 2007
  ident: R12-20250504
  article-title: Respiratory controversies in the critical care setting. Should noninvasive positive-pressure ventilation be used in all forms of acute respiratory failure?
  publication-title: Res Care
– volume: 49
  start-page: 270
  year: 2004
  ident: R17-20250504
  article-title: Factors affecting oxygen delivery with bi-level positive airway pressure
  publication-title: Resp Care
– volume: 38
  start-page: 1573
  year: 2012
  ident: R8-20250504
  article-title: The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-012-2682-1
– volume: 315
  start-page: 2435
  year: 2016
  ident: R18-20250504
  article-title: Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2016.6338
– volume: 148
  start-page: 501
  year: 1987
  ident: R10-20250504
  article-title: Pulmonary vascular obstruction in severe ARDS: angiographic alterations after iv fibrinolytic therapy
  publication-title: Am J Roentgenol
  doi: 10.2214/ajr.148.3.501
– volume: 307
  start-page: 2526
  year: 2012
  ident: R9-20250504
  article-title: Acute respiratory distress syndrome
  publication-title: JAMA
– volume: 91
  start-page: 1
  year: 2020
  ident: R6-20250504
  article-title: Prevalence, clinical manifestations, and biochemical data of hypertensive versus normotensive symptomatic patients with COVID-19: a comparative study
  publication-title: Acta Bio Medica Atenei Parmensis
– volume: 58
  start-page: 950
  year: 2013
  ident: R11-20250504
  article-title: Noninvasive ventilation for acute respiratory failure discussion
  publication-title: Resp Care
  doi: 10.4187/respcare.02319
– volume: 10
  start-page: 1
  year: 2020
  ident: R4-20250504
  article-title: Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-040428
– volume: 30
  start-page: 2450
  year: 2002
  ident: R2-20250504
  article-title: Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200211000-00008
– volume: 10
  start-page: 1
  year: 2004
  ident: R3-20250504
  article-title: Epidemiology of acute lung injury and acute respiratory distress syndrome
  publication-title: Curr Opin Crit Care
  doi: 10.1097/00075198-200402000-00001
SSID ssj0013724
Score 2.372725
Snippet The main aim of this study is to compare the use of non-invasive ventilation (NIV) via helmet versus face mask where different interfaces and masks can apply...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e24443
SubjectTerms Adolescent
Adult
Clinical Trials, Phase III as Topic
Critical Care Outcomes
Female
Head Protective Devices
Humans
Intensive Care Units
Length of Stay
Male
Masks
Middle Aged
Noninvasive Ventilation - instrumentation
Randomized Controlled Trials as Topic
Respiratory Distress Syndrome - therapy
Study Protocol Clinical Trial
Treatment Outcome
Young Adult
Title Comparison of the clinical outcomes of non-invasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005792-202101290-00099
https://www.ncbi.nlm.nih.gov/pubmed/33530249
https://www.proquest.com/docview/2486152923
https://pubmed.ncbi.nlm.nih.gov/PMC7850696
Volume 100
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: KQ8
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: KQ8
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 20241231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVALS
  databaseName: IngentaConnect Open Access Journals
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: FIJ
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: http://www.ingentaconnect.com/content/title?j_type=online&j_startat=Aa&j_endat=Af&j_pagesize=200&j_page=1
  providerName: Ingenta
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 20250917
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: RPM
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVOVD
  databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: OVEED
  dateStart: 19220501
  isFulltext: true
  titleUrlDefault: http://ovidsp.ovid.com/
  providerName: Ovid
– providerCode: PRVEMX
  databaseName: Wolters Kluwer Open Health
  customDbUrl:
  eissn: 1536-5964
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0013724
  issn: 0025-7974
  databaseCode: AGOPY
  dateStart: 19220101
  isFulltext: true
  titleUrlDefault: http://www.wkopenhealth.com/journals.php
  providerName: Wolters Kluwer Health
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZKJyEkhLhTLpOReCsZqeNc_AhrUYVUeGBDg5fISWw1apuiNS3afgK_jR_FsR0n6VpNjD5Ebey4bs9n-xz7nO8g9IYkQnLBmUN84TrU44nDYGlwsiyjAyF9FrkqdnjyORif0k9n_lmn86fltbQuk6P0cm9cyf9IFe6BXFWU7A0kWzcKN-A9yBeuIGG4_pOMj9tJBLUKWQc6LtclfKNhlAUL38mLDdee6tq_0TjAKdVzKuYLUfY3K5V5Ryz4atZv2FZt6FuqnAnOW4fyWV7FmOwjPJhUx_VKef3A52VufHkbr-4ptK6PgSbLKV_wrP_9qJmh4eELPpvpPASmAqjEP-oKo_lqyqXITamK_pK8_7VVfCkMCMe8yG1BtatB1JaGU3XERhkoKk2TwedI2Mk5cHxmWM_r2dt1WzClrblYgOZiKKB2lglDPzwZGvZK86prb5NyX1ksaxdGe3g_GcZXG7mFDkgYBKSLDr58G42GzalWSGidQhh-m2XBYuG7PX3Z1pR2zJ9dL967v5bKw2I10wEWLTXp5D66V9k3-L0B6wPUEcVDdNtC4hH63WAWLyUGzGKLWWwxqwramMUtzOLkAhvM4s0KW8zivMAWs1hhFmvM4hZmscUstph9jE4_jk6Ox06VD8RJvUgdBMogAlC5PE3AaGFgWxOe8YhSRlzpZikH5RXU9czlg5AzNdHAhMPlQAZJ5KeR5z1BXei9eIZwIqV0JYXFh1MakjTxhJcIsMWF-sz8HiL2v4_Tiixf5WyZx9fIvYfe1g_9NFwx11d_bYUaw5yuDup4IWDkxIRGYGgQsL166KkRct2g56k8X5T1ULgl_rqC4ovfLinyqeaNDxU7JQt6yNkCSmwirnX__JARR41HvT_taAPy-c1-1gt0pxnQL1G3PF-LV6C4l8mh3vA6rEbFX2xt7UU
linkProvider Ovid
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFD6CTgIkhLgTrkZCeSKQOs7FD32o2owyloLUjo2nyElsrdqWTEtaxF_gV-OT2ygTSOQliexEkc9x_PlcvgPwhiZSCSm4RV1pW8wRicX10mBlWcaGUrk8sDF3OJp7swO2d-QetdEWmAuD2Wfl-Ts81f9pvMB6OLgxXI72FuY8PFyMcnOymIy-mV_GH8LaTo1REuZ0VGxUZY7ndfyV63OqdYAOa1OLVWOh67DjYabmAHY-fw3D6aW_waesL-6qIXbHT8T999G04ThsDr0aMmd7DbsCTK_GV97-XqDvuzypQ99_W8B278KdFnmScaMq9-CazO_Djaj1rT-An5O-JCEpFNHAkHRpk6RYV3qYZIkNeZFbq3wjMO6d1NGSTTgdSX6QY3l6JiuyKYkSqTwT5QlZ5aTlbi0JGn2JSNeVJBeXLn6SrZqMFdLRJzyEg91wOZlZbaUGK3UCdNEoLxBK2CJNNJzketdDRSYCxji1lZ2lQsMKDaQyWwx9wVEFtCoINVReErhp4DiPYKC_Xj4BkiilbMX0b0Ew5tM0caSTSL1LknjPXQNoN_Zx2tKYYzWN07hzp0fT-E-BGfC2f-i8YfH4d_fXnVBjPdvQhSJyWazLmLJAQ0CqUbEBjxsh9y90HKzAxLgB_pb4-w7I5L3dkq-Oa0ZvH3kDuWeAtaUocZMLG_9NnZ_-Z_9XcHO2jPbj_Y_zT8_gFraiNYny5zCoLtbyhcZXVfKynRy_ADpMHU8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb5swFD7qUqmaNFW7j3UXT5p4GhMxJuAHHqpA1nVLWint1j4hA7YatYWqkEz9C_vV8-HWZZ0mjRdANpaFL-fzuXwH4D1NpBJScIu60raYIxKLa9FgZVnGhlK53Lcxdng6G-0ds_0T92QDOospBp-VVx_xVm_T-IDpcPBceBTsz83xfBycmrPo-zyYmYe7n6JaTY1OEuZhOAluzDAoVqoyw4Og42echg1JYXNpccace7Dpo-AdwObBtygKb-0OHmV9klcNtTueor83sy7L7gDUu36WD34UaAMvz2sX-N8E2eQhbLcIlOw2U-YRbMj8MWxNWxv7E_g57lMTkkIRDRBJFz5JimWl_5cssSAvcmuRrwT6v5Paa7JxqyPJDTmTF5eyIquSKJHKS1Gek0VOWg7XkqDyl4h0WUlyfWvqJ9miiVwhHY3CUzieREfjPavN2GCljo-mGjXyhRK2SBMNK7k-_VCRCZ8xTm1lZ6nQ8EIDqswWQ09wnAp6Sgg1VKPEd1PfcZ7BQPdevgCSKKVsxfT2IBjzaJo40kmkPi1JfOeuAbT793Ha0pljVo2LuDOrT8P4zwEz4EP_0VXD5vHv6u-6QY31qkNTishlsSxjynwNBalGxwY8bwa5b9BxMBMT4wZ4a8PfV0BG7_WSfHFWM3t7yB_IRwZYaxMlbmJi6_65Hqd6a6PDWoNo1RD_5X_WfwtberHEXz_PvuzAfSxEpRLlr2BQXS_law2zquRNuzZ-AW4vHtI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+the+clinical+outcomes+of+non-invasive+ventilation+by+helmet+vs+facemask+in+patients+with+acute+respiratory+distress+syndrome&rft.jtitle=Medicine+%28Baltimore%29&rft.au=Khatib%2C+Mohamad+Y.&rft.au=Peediyakkal%2C+Mohamed+Z.&rft.au=Elshafei%2C+Moustafa+S.&rft.au=Elzeer%2C+Hani+S.&rft.date=2021-01-29&rft.issn=0025-7974&rft.eissn=1536-5964&rft.volume=100&rft.issue=4&rft.spage=e24443&rft_id=info:doi/10.1097%2FMD.0000000000024443&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_MD_0000000000024443
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7974&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7974&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7974&client=summon